Emercell
Pre-clinicalParis, Franceemercell.com
Emercell is a biotech company bridging immunotherapy research projects to first pharmaceutical development steps
Focus
Cell & Gene Therapy
About
Emercell is a biotech company bridging immunotherapy research projects to first pharmaceutical development steps
Funding History
2Total raised: $14.5M
Series A$12MSofinnova PartnersNov 15, 2022
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
LocationParis, France
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile